Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 5/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CCR2 | P41597 | 5/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CCR1 | P32246 | 1/20 | 0.35 |
| ▸ | CCR5 | P51681 | 1/20 | 0.35 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6887346 | 0.94 | CYP19A1 (0.43) | CYP19A1KDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL5857915 | 0.92 | CYP19A1 (0.45) | CYP19A1ALDH1A1CCR2NAAACCR1 | |
| SCHEMBL8676129 | 0.92 | CYP19A1 (0.45) | CYP19A1ALDH1A1CCR2NAAACCR1 | |
| SCHEMBL17187540 | 0.92 | CYP19A1 (0.45) | CYP19A1ALDH1A1CCR2NAAACCR1 | |
| SCHEMBL24919786 | 0.92 | CYP19A1 (0.45) | CYP19A1ALDH1A1CCR2NAAACCR1 | |
| SCHEMBL5754395 | 0.89 | CCR2 (0.42) | CYP19A1KDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL2485204 | 0.88 | — | — | |
| SCHEMBL30522495 | 0.88 | — | — | |
| SCHEMBL8376974 | 0.88 | — | — | |
| SCHEMBL1706310 | 0.87 | CCR2 (0.48) | CYP19A1KDM4EMEN1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017012963-A1 | POLYMERIZABLE FATTY ACID-DERIVATIVE-MONOMERS WITH TERMINAL OLEFINIC DOUBLE BONDS, POLYMERS CONTAINING SAME MONOMERS, PRODUCTION AND USE THEREOF | BASF SE (DE) | 2017-01-26 | — | — | WO | claimed |
| US-20080182773-A1 | Thickeners Based on Polymers Comprising Amine Groups | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-31 | — | — | US | claimed |
| EP-1863574-A1 | THICKENER BASED ON AMINE GROUP-CONTAINING POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-12 | — | — | EP | claimed |
| WO-2006100299-A1 | THICKENER BASED ON AMINE GROUP-CONTAINING POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-28 | — | — | WO | claimed |
| CN-119552574-A | Method for using light absorbing release composition and method for preparing semiconductor device | 奇美实业股份有限公司 | 2025-03-04 | — | — | CN | disclosed |
| US-20220402950-A1 | SUBSTITUTED BENZIMIDAZOLES AS PAD4 INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2022-12-22 | — | — | US | disclosed |
| EP-2170964-B1 | HIGH-CATION COPOLYMERS BASED ON QUATERNIZED NITROGEN-CONTAINING MONOMERS | BASF SE (DE) | 2017-02-22 | — | — | EP | disclosed |
| WO-2017012963-A1 | POLYMERIZABLE FATTY ACID-DERIVATIVE-MONOMERS WITH TERMINAL OLEFINIC DOUBLE BONDS, POLYMERS CONTAINING SAME MONOMERS, PRODUCTION AND USE THEREOF | BASF SE (DE) | 2017-01-26 | — | — | WO | disclosed |
| US-8623343-B2 | Highly cationic copolymers based on quaternized nitrogen-containing monomers | BASF SE (DE) | 2014-01-07 | — | — | US | disclosed |
| US-20130108959-A1 | USE OF A COMPOSITION COMPRISING VINYL MONOMER-COMPRISING POLYMER, SOLVENT AND AT LEAST ONE HALOGEN-FREE BIOCIDE | BASF SE (DE) | 2013-05-02 | — | — | US | disclosed |
| WO-2013060679-A1 | USE OF A COMPOSITION CONTAINING VINYL-LACTAM-CONTAINING POLYMER, SOLVENT AND AT LEAST ONE HALOGEN-FREE BIOCIDE AS A METAL-QUENCHING MEDIUM | BASF SE (DE) | 2013-05-02 | — | — | WO | disclosed |
| WO-2012065928-A1 | AQUEOUS METAL QUENCHING MEDIUM | BASF SE (DE) | 2012-05-24 | — | — | WO | disclosed |
| US-6066666-A | OPTIONALLY N-SUBSTITUTED 3-MONO- AND DI-SUBSTITUTED 2-PYRROLIDINONES AND THIOLACTAM ANALOGS; TREAT SEIZURES, ANXIETY, AND ENHANCING 4-AMINOBUTYRIC ACID (GABA)-INDUCED CHLORIDE CURRENTS AT GABA RECEPTOR/IONOPHORE COMPLEX | WASHINGTON UNIVERSITY (US) | 2000-05-23 | — | — | US | disclosed |
| WO-1999064426-A1 | HETEROBICYCLIC AND TRICYCLIC NITRIC OXIDE SYNTHASE INHIBITORS | G.D. SEARLE & CO. (US) | 1999-12-16 | — | — | WO | disclosed |
| US-5776959-A | Anticonvulsant and anxiolytic lactam and thiolactam derivatives | WASHINGTON UNIVERSITY (US) | 1998-07-07 | — | — | US | disclosed |
| EP-0005689-B1 | LACTAM-N-ACETIC ACIDS, THEIR AMIDES, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS CONTAINING THEM | U C B, S.A. (BE) | 1981-03-18 | — | — | EP | disclosed |
| US-4221789-A | MEMORY, CARDIOVASCULAR DISORDERS | UCB, SOCIETE ANONYME (BE) | 1980-09-09 | — | — | US | disclosed |
| EP-0005689-A1 | Lactam-N-acetic acids, their amides, process for their preparation and therapeutic compositions containing them | U C B, S.A. (BE) | 1979-11-28 | — | — | EP | disclosed |
| US-4087270-A | WEED CONTROL | GAF CORPORATION (US) | 1978-05-02 | — | — | US | disclosed |
| US-4086356-A | Fungicidal-N-(3-halo-2,6-dinitro-4-trifluoromethylphenyl)-pyrrolidones | GAF CORPORATION (US) | 1978-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220402950-A1 | SUBSTITUTED BENZIMIDAZOLES AS PAD4 INHIBITORS | PADI4, PADI1, PADI6 | CYP19A1 1318/4885KDM4E 62/4885MEN1 4059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.